Table 1 Demographic, past medical history, and instrumental swallowing assessment (FEES or VFSS) information for patient cohort
Parameters | N of 88 (%) | |
|---|---|---|
Median age (range) | 18 months (2–99) | |
Males | 54 (61%) | |
Median follow-up (range) | 14 months (4–54) | |
Comorbidity | SDB | 22 (25%) |
Asthma | 4 (5%) | |
GERD | 47 (53%) | |
Neurological impairment | 7 (8%) | |
Dysmorphism/syndrome | 9 (10%) | |
Ex-prematurity | 21 (24%) | |
None | 19 (22%) | |
Secondary airway lesion | Laryngomalacia | 2 (2%) |
Laryngeal dyskinesia/immobility | 3 (3%) | |
Vocal cord nodules | 2 (2%) | |
TEF | 2 (2%) | |
Tracheomalacia | 5 6%) | |
Presenting symptom | Choking (liquids) | 60 (68%) |
Choking (solids) | 33 (38%) | |
Recurrent pneumonia | 42 (48%) | |
Stridor | 28 (32%) | |
Cyanotic spells | 11 (13%) | |
ALTE | 3 (3%) | |
Instrumental swallowing assessment findings | Laryngeal penetration | 77 (88%) |
Aspiration | 37 (42%) | |
Silent aspiration | 34 (39%) | |